PARISI, GIUSEPPE FABIO
 Distribuzione geografica
Continente #
NA - Nord America 1.593
AS - Asia 953
EU - Europa 723
SA - Sud America 139
AF - Africa 118
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 3.530
Nazione #
US - Stati Uniti d'America 1.551
SG - Singapore 472
CN - Cina 338
IT - Italia 275
IE - Irlanda 191
BR - Brasile 120
CI - Costa d'Avorio 72
DE - Germania 71
KR - Corea 52
UA - Ucraina 48
RU - Federazione Russa 45
CA - Canada 33
SN - Senegal 25
IN - India 24
GB - Regno Unito 21
CZ - Repubblica Ceca 15
HK - Hong Kong 14
NG - Nigeria 14
NL - Olanda 14
VN - Vietnam 10
FI - Finlandia 8
FR - Francia 8
CH - Svizzera 7
IQ - Iraq 7
JP - Giappone 7
MX - Messico 7
PE - Perù 6
PL - Polonia 6
BD - Bangladesh 5
SE - Svezia 5
TR - Turchia 5
AR - Argentina 4
ZA - Sudafrica 4
AT - Austria 3
EC - Ecuador 3
GR - Grecia 3
UZ - Uzbekistan 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
AZ - Azerbaigian 2
CL - Cile 2
CO - Colombia 2
IL - Israele 2
KG - Kirghizistan 2
LB - Libano 2
TH - Thailandia 2
BG - Bulgaria 1
DO - Repubblica Dominicana 1
ES - Italia 1
ET - Etiopia 1
EU - Europa 1
HN - Honduras 1
KZ - Kazakistan 1
LT - Lituania 1
MN - Mongolia 1
NR - Nauru 1
OM - Oman 1
PK - Pakistan 1
PY - Paraguay 1
TG - Togo 1
TN - Tunisia 1
VE - Venezuela 1
Totale 3.530
Città #
Santa Clara 458
Singapore 337
Dublin 191
Chandler 179
Hefei 148
Chicago 106
Ashburn 86
Abidjan 72
Boardman 68
Civitanova Marche 65
Seoul 51
Cambridge 50
Jacksonville 50
Lawrence 50
Beijing 40
Andover 38
Catania 34
Nanjing 28
Bremen 26
Dakar 25
Des Moines 24
Los Angeles 19
Toronto 18
Saint Petersburg 17
Milan 16
Wilmington 15
Abuja 14
Brno 13
Hong Kong 13
Council Bluffs 11
Rome 11
San Francisco 11
Washington 11
Brooklyn 10
São Paulo 10
Nanchang 9
New York 9
Tokyo 7
Amsterdam 6
Frankfurt am Main 6
Redwood City 6
Shenyang 6
Arequipa 5
Genoa 5
Hanoi 5
Hebei 5
Munich 5
Palermo 5
San Mateo 5
Tianjin 5
Turin 5
Turku 5
Warsaw 5
Ankara 4
Baghdad 4
Bernareggio 4
Changsha 4
Columbus 4
Dong Ket 4
Pune 4
Stockholm 4
The Dalles 4
Bari 3
Charlotte 3
Chennai 3
Dhaka 3
Falls Church 3
Favara 3
Guangzhou 3
Jiaxing 3
Lappeenranta 3
Mascalucia 3
Messina 3
Mexico City 3
Misterbianco 3
Montreal 3
Mumbai 3
Naples 3
Ottawa 3
Pinhais 3
Reggio Emilia 3
Seattle 3
Altamura 2
Ansbach 2
Atlanta 2
Baku 2
Bangkok 2
Basel 2
Belo Horizonte 2
Birmingham 2
Bishkek 2
Boston 2
Brescia 2
Cagliari 2
Costa di Rovigo 2
Curitiba 2
Delhi 2
Duque de Caxias 2
Enna 2
Esslingen am Neckar 2
Totale 2.551
Nome #
General anesthesia, conscious sedation, or nothing: Decision-making by children during painful procedures 83
YKL-40 as marker of severe lung disease in cystic fibrosis patients. 77
Serum YKL-40 in children with asthma 75
SAFETY AND EFFICACY OF SUBLINGUAL SPECIFIC IMMUNOTHERAPY TO HOUSE DUST MITE USING A DIFFERENT DOSAGE: A PILOT STUDY. 72
HMGB1 as a new biomarker of celiac disease in children: a multicenter study 68
Successful treatment with omalizumab of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: Case reports and literature review 68
Clinical efficacy and safety of omalizumab in conventional treatment-resistant vernal keratoconjunctivitis: Our experience and literature review 68
Impact of COVID-19 Pandemic and Lockdown on the Epidemiology of RSV-Mediated Bronchiolitis: Experience from Our Centre 67
Positive impact of insulin treatment on clinical trend in cystic fibrosis patients: a retrospective study 66
Pilot study shows right ventricular diastolic function impairment in young children with obstructive respiratory disease 66
Exhaled markers of antioxidant activity and oxidative stress in stable cystic fibrosis patients with moderate lung disease 65
Lung clearance index: A new measure of late lung complications of cancer therapy in children 65
The Role of Ultrasound in the Diagnosis of Pulmonary Infection Caused by Intracellular, Fungal Pathogens and Mycobacteria: A Systematic Review 64
Cystic Fibrosis and Cancer: Unraveling the Complex Role of CFTR Gene in Cancer Susceptibility 64
Focus on pleiotropic role of HMGB1 in the onset of allergic and non- allergic respiratory diseases 64
Minor pulmonary malformations in a child 64
HMGB1 values and response to HBV vaccine in children with celiac disease 63
Lactoferrin: Cytokine modulation and application in clinical practice 63
Severe Kawasaki disease in a 3-month-old patient: a case report. 62
Hypertransaminasemia in children is not always as simple as it seems 62
Liver disease in Cystic Fibrosis: an update 61
Exhaled breath temperature in astmatic children 61
LUNG CLEARANCE INDEX: a new biomarker of ventilation inhomogeneity in pediatric respiratory diseases. 60
Cetirizine use in childhood: An update of a friendly 30-year drug 58
Nutraceuticals in the prevention of viral infections, including covid-19, among the pediatric population: A review of the literature 57
Novel therapeutic targets for allergic airway disease in children 56
Lung clearance index evaluation in detecting nocturnal hypoxemia in cystic fibrosis patients: Toward a new diagnostic tool 56
Proposal for a new therapeutic high dosage of Pidotimod in children with periodic fever, aphthous stomatitis, pharyngitis, adenitis (PFAPA) syndrome: A randomized controlled study 55
High mobility Group box 1: Biomarker of inhaled corticosteroid treatment response in children with moderate - severe asthma 54
Biomarkers in pediatric lung diseases including cystic fibrosis 53
Genetic disorders of surfactant deficiency and neonatal lung disease 53
Gastroesophageal reflux and respiratory diseases: Does a real link exist? 52
Antihistamines in children and adolescents: A practical update 52
Severe disease in Cystic Fibrosis and fecal calprotectin levels 51
Phenotypic expression of the p.Leu1077Pro CFTR mutation in Sicilian cystic fibrosis patients 51
Nocturnal non invasive ventilation in normocapnic cystic fibrosis patients: A pilot study 51
Cystic Fibrosis: Fighting Together Against Coronavirus Infection 50
Focus on gastroesophageal reflux disease in patients with cystic fibrosis 50
Nasal Nitric Oxide and Nasal Cytology as Predictive Markers of Short-Term Sublingual Allergen-Specific Immunotherapy Efficacy in Children with Allergic Rhinitis 49
Monoclonal antibodies in treating food allergy: A new therapeutic horizon 49
Lung clearance index for evaluation of late complications of cancer therapy in children 48
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: A pilot study on short-term efficacy 48
Antihistamines: ABC for the pediatricians 48
The immunomodulatory role of vitamin D in respiratory diseases 47
Lower airway microbiota 46
Nonresponse to intramuscular vaccination: An unmet need in hepatitis B vaccination 46
Serum interleukin 17, interleukin 23, and interleukin 10 values in children with atopic eczema/dermatitis syndrome (AEDS): association with clinical severity and phenotype 45
Targeted Therapy for Severe Asthma in Children and Adolescents: Current and Future Perspectives 45
Small airways in children with allergic rhinoconjunctivitis: The potential role of a multicomponent nutraceutical 41
Looking beyond pulmonary disease in COVID-19: A lesson from patients with cystic fibrosis 41
Leukotriene receptor antagonist drugs: A tool to face chronic urticaria in children? 40
Omalizumab treatment in a 12 year-old girl with chronic spontaneous urticaria 40
Long-term effects of bronchopulmonary dysplasia on lung function: a pilot study in preschool children’s cohort 40
Comparative Analysis of Pediatric Hospitalizations during Two Consecutive Influenza and Respiratory Virus Seasons Post-Pandemic 39
Type 2 inflammation in cystic fibrosis: New insights 39
Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study 34
Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cardiorespiratory Polygraphy Parameters and Respiratory Muscle Strength in Cystic Fibrosis Patients with Severe Lung Disease 34
Respiratory symptoms in a child with IgE-non-dependent hypersensitivity to wheat 34
Cystic fibrosis transmembrane conductance regulator (CFTR): beyond cystic fibrosis 32
Upper and lower airways diseases in childhood 32
Effect of Dornase Alfa on the Lung Clearance Index in Children with Cystic Fibrosis: A Lesson from a Case Series 31
Fungi and non-tuberculous mycobacteria: emerging pathogens in cystic fibrosis 31
Biologic drugs in treating allergic bronchopulmonary aspergillosis in patients with cystic fibrosis: a systematic review 30
Cystic Fibrosis and Oxidative Stress: The Role of CFTR 29
Combining biologics and CFTR modulators is safe: A pilot, observational, monocenter study 29
Protracted bacterial bronchitis: more to know 29
Pathogenesis, diagnosis, dietary management, and prevention of gastrointestinal disorders in the paediatric population 27
Nasal microbiome in chronic rhinosinusitis 26
Addition of a nutraceutical to montelukast or inhaled steroid in the treatment of wheezing during COVID-19 pandemic: a multicenter, open-label, randomized controlled trial 26
Interstitial Lung Disease in Children: “Specific Conditions of Undefined Etiology” Becoming Clearer 26
Monoclonal Antibodies in Treating Chronic Spontaneous Urticaria: New Drugs for an Old Disease 25
Efficacy and perceived satisfaction of 3-year SLIT in children with allergic rhinitis and asthma: a pilot study 23
Pidotimod in allergic diseases 23
Foreign Body Aspiration in Children: Retrospective Case Series and Literature Update 21
Safety of biologics in severe asthmatic patients with SARS‐CoV‐2 infection: A prospective study 18
Sleep Respiratory Disorders in Children and Adolescents with Cystic Fibrosis and Primary Ciliary Dyskinesia 15
Totale 3.653
Categoria #
all - tutte 16.968
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.968


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021154 0 5 20 12 39 20 18 2 6 15 10 7
2021/2022295 17 42 1 3 43 2 39 10 26 3 7 102
2022/2023656 50 12 36 42 55 109 4 120 160 6 35 27
2023/2024394 15 39 30 25 26 114 3 31 0 1 67 43
2024/20251.581 47 188 68 112 292 296 45 27 73 145 154 134
2025/2026411 249 162 0 0 0 0 0 0 0 0 0 0
Totale 3.653